(Q83710870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

10

Kazuhiko Koike

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Koji Uchino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Shuichiro Shiina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Miho Kanda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ryota Masuzaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Yuji Kondo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Tadashi Goto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Masao Omata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Haruhiko Yoshida

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

22 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

4475-4483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Extrahepatic Metastases of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Systemic therapy for advanced hepatocellular carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Regression modelling strategies for improved prognostic prediction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Clinical features of hepatocellular carcinoma with extrahepatic metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Treatment of lymph node recurrence in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Management of adrenal metastasis from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Intracranial metastasis of hepatocellular carcinoma: review of 45 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25960

7 January 2021

Identifiers

DOI

10.1002/CNCR.25960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21437884%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference